Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.933
+0.033 (3.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Company Description
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.
The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.
It also offers LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures.
Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company was founded in 2007 and is based in Fort Mill, South Carolina.
Catheter Precision, Inc.
| Country | United States |
| Founded | 2002 |
| IPO Date | Aug 30, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 22 |
| CEO | David Jenkins |
Contact Details
Address: 1670 Highway 160 West, Suite 205 Fort Mill, South Carolina 29708 United States | |
| Phone | 973 691 2000 |
| Website | catheterprecision.com |
Stock Details
| Ticker Symbol | VTAK |
| Exchange | NYSEAMERICAN |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001716621 |
| CUSIP Number | 74933X708 |
| ISIN Number | US74933X7084 |
| Employer ID | 38-3661826 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Jenkins | Chief Executive Officer, Chief Commercial Officer and Executive Chairman |
| Philip J. Anderson | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2026 | 8-K | Current Report |
| Apr 15, 2026 | 8-K | Current Report |
| Mar 31, 2026 | 8-K | Current Report |
| Mar 31, 2026 | 10-K | Annual Report |
| Mar 23, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 23, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 13, 2026 | PRE 14A | Other preliminary proxy statements |
| Mar 9, 2026 | 8-K | Current Report |
| Feb 13, 2026 | SCHEDULE 13G | Filing |
| Feb 12, 2026 | 8-K | Current Report |